Showing 20 articles starting at article 1
Published Fecal microbiota transplant recommended for the majority of recurrent C. diff patients (via sciencedaily.com) Original source
In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection. FMT therapies are not recommended as a treatment for inflammatory bowel diseases (IBD) or irritable bowel syndrome (IBS).
Published Chronic fatigue syndrome: Number of patients is expected to double due to long-term effects of the COVID-19 pandemic (via sciencedaily.com) Original source
The number of ME/CFS patients is expected to rise drastically due to long-term effects of the COVID-19 pandemic. Scientists have now identified possible biomarkers that could improve the diagnosis and treatment of long-lasting and debilitating fatigue.
Published Risk of serious infection even in low-active IBD (via sciencedaily.com) Original source
Inflammatory bowel disease (IBD) is an independent risk factor for serious infection, even at very low levels of gastrointestinal inflammation.
Published Genetics links endometriosis and IBS (via sciencedaily.com) Original source
Researchers have found a significant relationship between the risks for endometriosis and common gastrointestinal disorders such as IBS, peptic ulcer disease (PUD) and gastro-oesophageal reflux disease (GORD). Sufferers can find it difficult to distinguish the source of their pain leading to confusion or misdiagnosis and years of delay in treatment during which time the endometriosis can progress to more severe disease -- endometriosis should be considered as a possible cause if a woman presents to her GP with abdominal pain and gastrointestinal symptoms.
Published Amitriptyline helps relieve IBS symptoms (via sciencedaily.com) Original source
Amitriptyline can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research has found. The cheap and widely available prescription drug, which is commonly used at low doses for a range of health concerns, has been found to improve irritable bowel syndrome (IBS) symptoms too, according to the results of the ATLANTIS trial. The results showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms as those taking a placebo.
Published Women more severely affected by chronic fatigue syndrome (via sciencedaily.com) Original source
Women with ME/CFS tend to have more symptoms and co-occurring conditions than men, according to initial results from the world's largest study of the disease. It has long been known that women are more likely to have ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) but the DecodeME study has shown for the first time how their experience differs from men.
Published Fiber discovery could shape better gut health (via sciencedaily.com) Original source
Changing the structure of a dietary fiber commonly found in a range of food products has been found to promote healthy gut bacteria and reduce gas formation, a finding that could help people with intolerances to fiber and irritable bowel conditions.
Published Studies find that microbiome changes may be a signature for ME/CFS (via sciencedaily.com) Original source
Researchers have found differences in the gut microbiomes of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy controls. Findings from two studies add to growing evidence that connects disruptions in the gut microbiome, the complete collection of bacteria, viruses, and fungi that live in our gastrointestinal system, to ME/CFS.
Published Lower bacterial diversity is associated with irritable bowel syndrome (via sciencedaily.com) Original source
People with irritable bowel syndrome (IBS) have lower bacterial diversity in the intestine than do healthy people, according to a team of investigators. The investigators believe that theirs is the first analysis to find a clear association between IBS and reduced diversity in the microbiota of the gut.
Published Realtime monitoring with a wearable device reveals IBS-related changes (via sciencedaily.com)
A research group recorded the autonomic nervous system activity in patients with irritable bowel syndrome (IBS) and healthy subjects using a wearable device and a proprietary smartphone application to record daily life events such as defecation and sleep. As a result, they found that sympathetic nervous system activity was activated in IBS patients from 2 minutes before defecation and continued until 9 minutes after defecation. Further research is expected to improve the quality of life of IBS patients and elucidate the pathophysiology.
Published Treating gut pain via a Nobel prize-winning receptor (via sciencedaily.com)
Targeting a receptor responsible for our sense of touch and temperature, which researchers have now found to be present in our colon, could provide a new avenue for treating chronic pain associated with gastrointestinal disorders such as irritable bowel syndrome. A team examining the colon identified the presence of Piezo2, the subject of the 2021 Nobel Prize in Physiology or Medicine, now known to be responsible for sensing light touch on our skin.
Published How gravity may cause irritable bowel syndrome (via sciencedaily.com) Original source
A new theory suggests irritable bowel syndrome (IBS), the most common gastrointestinal disorder, may be caused by gravity. An expert explains that IBS -- and many other conditions -- could result from the body's inability to manage gravity.
Published Bloating common issue among Americans (via sciencedaily.com) Original source
Nearly 1 in 7 Americans experience bloating on a weekly basis, and most aren't seeking professional care for it, according to a new study.
Published Adverse pregnancy outcomes in women with inactive inflammatory bowel disease (via sciencedaily.com)
Inflammatory bowel disease is a risk factor for giving birth preterm even when in apparent disease remission, a new study shows. If corroborated, the results may eventually affect recommendations for women with ulcerative colitis who tries to conceive.
Published SARS-CoV-2 can trigger chronic fatigue syndrome, study finds (via sciencedaily.com)
Since the beginning of the pandemic, SARS-CoV-2 has been suspected of causing chronic fatigue syndrome (ME/CFS). A well-controlled study has now shown that, even after mild COVID-19, a subset of patients will develop symptoms which meet the diagnostic criteria for ME/CFS. Their findings also describe a second subset of post-COVID patients with similar symptoms. Differences in laboratory results between these groups may indicate differences in underlying mechanisms.
Published Histamine-producing gut bacteria can trigger chronic abdominal pain (via sciencedaily.com) Original source
The culprit is what has now been named Klebsiella aerogenes, the McMaster-Queen (MQ) strain, identified in up to 25 per cent of gut microbiota samples from patients with IBS. Researchers examined stool microbiota samples from both Canadian and American patient cohorts.
Published New research provides insight into Long COVID and ME (via sciencedaily.com) Original source
Researchers have uncovered how post-viral fatigue syndromes, including Long COVID, become life-changing diseases and why patients suffer frequent relapses.
Published How herpesviruses awaken (via sciencedaily.com) Original source
Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA.
Published Researchers highlight COVID-19 neurological symptoms and need for rigorous studies (via sciencedaily.com) Original source
In a new article, experts highlight what is currently known about the effects of SARS-CoV-2 on the brain, the importance of increased research into the underlying causes of Long COVID and possible ways to treat its symptoms.
Published For IBS, specific diets are less important than expected (via sciencedaily.com)
Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study does not show a relationship between high intake of gluten and increased IBS symptoms. The researchers did find that a certain type of carbohydrate called 'fodmaps' can aggravate intestinal problems, however, the overall results indicate that they also have less influence than previously thought.